Home LiteratureArticle Details
PMID: 18513999 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery.

Immunity ·Vol. 28 ·No. 6 ·2008-06-00 ·Pages 870-80

Ito T, Hanabuchi S, Wang YH, Park WR, Arima K, Bover L, Qin FX, Gilliet M, Liu YJ

Abstract

Previous studies suggest that thymus produces a homogenous population of natural regulatory T (Treg) cells that express a transcriptional factor FOXP3 and control autoimmunity through a cell-contact-dependent mechanism. We found two subsets of FOXP3+ natural Treg cells defined by the expression of the costimulatory molecule ICOS in the human thymus and periphery. Whereas the ICOS+FOXP3+ Treg cells used interleukin-10 to suppress dendritic cell function and transforming growth factor (TGF)-beta to suppress T cell function, the ICOS-FOXP3+ Treg cells used TGF-beta only. The survival and proliferation of the two subsets of Treg cells were differentially regulated by signaling through ICOS or CD28, respectively. We suggest that the selection of natural Treg cells in thymus is coupled with Treg cell differentiation into two subsets imprinted with different cytokine expression potentials and use both cell-contact-dependent and independent mechanisms for immunosuppression in periphery.

MeSH Terms
Antigens, Differentiation, T-Lymphocyte/immunology,metabolism CD28 Antigens/metabolism Cell Proliferation Cell Survival Cells, Cultured Dendritic Cells/immunology,metabolism Forkhead Transcription Factors/metabolism Humans Inducible T-Cell Co-Stimulator Protein Interleukin-10/immunology,metabolism Signal Transduction T-Lymphocyte Subsets/cytology,immunology,metabolism T-Lymphocytes, Regulatory/cytology,immunology,metabolism Thymus Gland/cytology,immunology,metabolism Transforming Growth Factor beta/immunology,metabolism
Chemicals
Antigens, Differentiation, T-Lymphocyte CD28 Antigens FOXP3 protein, human Forkhead Transcription Factors ICOS protein, human Inducible T-Cell Co-Stimulator Protein Transforming Growth Factor beta Interleukin-10
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Ito Tomoki
Department of Immunology and Center of Cancer Immunology Research, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Hanabuchi Shino
Wang Yi-Hong
Park Woong Ryeon
Arima Kazuhiko
Bover Laura
Qin F Xiao-Feng
Gilliet Michel
Liu Yong-Jun
References (54)
54 references, click to expand
  1. Control of regulatory T cell development by the transcription factor Foxp3.
    Science. 2003 Feb 14;299(5609):1057-61 PMID: 12522256
  2. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.
    Nat Immunol. 2003 Apr;4(4):330-6 PMID: 12612578
  3. The interactions of dendritic cells with antigen-specific, regulatory T cells that suppress autoimmunity.
    Semin Immunol. 2006 Apr;18(2):93-102 PMID: 16469503
  4. MHC class II expression identifies functionally distinct human regulatory T cells.
    J Immunol. 2006 Apr 15;176(8):4622-31 PMID: 16585553
  5. Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand.
    J Exp Med. 2007 Jan 22;204(1):105-15 PMID: 17200410
  6. Reciprocal control of T helper cell and dendritic cell differentiation.
    Science. 1999 Feb 19;283(5405):1183-6 PMID: 10024247
  7. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity.
    Nat Med. 2002 Sep;8(9):1024-32 PMID: 12145647
  8. Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro.
    Eur J Immunol. 2001 Apr;31(4):1247-54 PMID: 11298351
  9. Inducing and expanding regulatory T cell populations by foreign antigen.
    Nat Immunol. 2005 Dec;6(12):1219-27 PMID: 16244650
  10. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells.
    J Exp Med. 1994 Feb 1;179(2):493-502 PMID: 7905018
  11. An essential role for Scurfin in CD4+CD25+ T regulatory cells.
    Nat Immunol. 2003 Apr;4(4):337-42 PMID: 12612581
  12. Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis.
    J Immunol. 2007 Jul 15;179(2):1322-30 PMID: 17617625
  13. A central role for peripheral dendritic cells in the induction of acquired thymic tolerance.
    Trends Immunol. 2003 Feb;24(2):77-81 PMID: 12547504
  14. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production.
    J Exp Med. 1998 Jul 20;188(2):287-96 PMID: 9670041
  15. Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population.
    Eur J Immunol. 2001 Apr;31(4):1122-31 PMID: 11298337
  16. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells.
    J Exp Med. 2006 Jul 10;203(7):1693-700 PMID: 16818676
  17. Follicular B helper T cell activity is confined to CXCR5(hi)ICOS(hi) CD4 T cells and is independent of CD57 expression.
    Eur J Immunol. 2006 Jul;36(7):1892-903 PMID: 16791882
  18. Natural type I interferon-producing cells as a link between innate and adaptive immunity.
    Hum Immunol. 2002 Dec;63(12):1126-32 PMID: 12480256
  19. A peripheral circulating compartment of natural naive CD4 Tregs.
    J Clin Invest. 2005 Jul;115(7):1953-62 PMID: 16007258
  20. Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus.
    Nature. 2005 Aug 25;436(7054):1181-5 PMID: 16121185
  21. Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells.
    Nat Immunol. 2007 Apr;8(4):351-8 PMID: 17322887
  22. Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood.
    J Exp Med. 2002 Mar 18;195(6):789-94 PMID: 11901204
  23. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid.
    J Exp Med. 2007 Aug 6;204(8):1775-85 PMID: 17620362
  24. Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells.
    Immunol Rev. 2001 Aug;182:207-14 PMID: 11722636
  25. Eminent role of ICOS costimulation for T cells interacting with plasmacytoid dendritic cells.
    Immunology. 2006 Jul;118(3):353-60 PMID: 16827896
  26. The role of different subsets of T regulatory cells in controlling autoimmunity.
    Curr Opin Immunol. 2000 Dec;12(6):676-83 PMID: 11102772
  27. Macrophage-derived chemokine and EBI1-ligand chemokine attract human thymocytes in different stage of development and are produced by distinct subsets of medullary epithelial cells: possible implications for negative selection.
    J Immunol. 2000 Jul 1;165(1):238-46 PMID: 10861057
  28. Regulatory T cells.
    Curr Opin Pharmacol. 2004 Aug;4(4):408-14 PMID: 15251137
  29. IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells.
    J Immunol. 2004 May 15;172(10):5986-93 PMID: 15128781
  30. Expression of ICOS in vivo defines CD4+ effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10.
    J Exp Med. 2003 Jan 20;197(2):181-93 PMID: 12538658
  31. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28.
    Nature. 1999 Jan 21;397(6716):263-6 PMID: 9930702
  32. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis.
    Nature. 1997 Oct 16;389(6652):737-42 PMID: 9338786
  33. CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness.
    J Exp Med. 2002 Jul 15;196(2):237-46 PMID: 12119348
  34. CD25+CD4+ T cells in human cord blood: an immunoregulatory subset with naive phenotype and specific expression of forkhead box p3 (Foxp3) gene.
    Exp Hematol. 2004 Jul;32(7):622-9 PMID: 15246158
  35. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis.
    Science. 1994 Aug 26;265(5176):1237-40 PMID: 7520605
  36. Persistence of naive CD45RA+ regulatory T cells in adult life.
    Blood. 2006 Apr 1;107(7):2830-8 PMID: 16332974
  37. A unified theory of central tolerance in the thymus.
    Trends Immunol. 2006 May;27(5):215-21 PMID: 16580260
  38. T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells.
    J Exp Med. 2005 Mar 7;201(5):737-46 PMID: 15753207
  39. Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse.
    Immunity. 2006 Dec;25(6):941-52 PMID: 17137799
  40. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis.
    J Exp Med. 2002 Jan 21;195(2):221-31 PMID: 11805149
  41. Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis.
    J Immunol. 2006 Nov 1;177(9):5852-60 PMID: 17056509
  42. Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells.
    J Exp Med. 2001 Aug 20;194(4):427-38 PMID: 11514600
  43. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity.
    Nature. 2002 Dec 5;420(6915):502-7 PMID: 12466842
  44. Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells.
    J Exp Med. 2002 Nov 18;196(10):1335-46 PMID: 12438424
  45. Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes.
    J Exp Med. 2002 Aug 5;196(3):379-87 PMID: 12163566
  46. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells.
    J Exp Med. 2006 Jul 10;203(7):1701-11 PMID: 16818678
  47. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism.
    J Exp Med. 2007 Aug 6;204(8):1757-64 PMID: 17620361
  48. Regulatory T cells and mechanisms of immune system control.
    Nat Med. 2004 Aug;10(8):801-5 PMID: 15286781
  49. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta.
    J Exp Med. 2001 Sep 3;194(5):629-44 PMID: 11535631
  50. Maintenance and polarization of human TH2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells.
    Immunity. 2006 Jun;24(6):827-838 PMID: 16782037
  51. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation.
    J Exp Med. 1999 Oct 4;190(7):995-1004 PMID: 10510089
  52. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood.
    J Exp Med. 2001 Jun 4;193(11):1285-94 PMID: 11390435
  53. Interleukin 10 is a growth factor for a population of regulatory T cells.
    Gut. 1998 Feb;42(2):157-8 PMID: 9536936
  54. CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes.
    Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10878-83 PMID: 12949259
Article Info
Journal
Immunity
Abbr.
Immunity
ISSN
1097-4180
Published
2008-06-00
Epub
2008-00-29
Pages
870-80
Language
English
Region
United States
NLM ID
9432918
PMCID
PMC2709453
Subset
IM
Grants
NIAID NIH HHS · R01 AI062888 · United States
NIAID NIH HHS · R01 AI062888-05 · United States
NIAID NIH HHS · U19 AI071130 · United States
NIAID NIH HHS · U19 AI071130-01 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com